Let's get this straight, since the disturbed basher posted

New Post Public Reply Private Reply Replies (2) Message Board
Drano
553
Let's get this straight, since the disturbed basher posted a lie that some may have seen.

The initial ULCERATIVE PROCTITIS ("UP" ) clinical trial administered a small amount of Brilacidin via enema. This is the clinical trial that had a spectacular success, and we have dramatic photographic before-and-after evidence of the success.

THIS clinical trial is for a "time-release" version of the drug, intended to make it through the stomach without dissolving, and then releasing the Brilacidin into the intestinal tract, to attempt treatment of ulcerative COLITIS, which is further up the intestinal tract than what an enema can reach.

It is entirely possible that BOTH forms of the drug could be submitted for approval. If someone has only Ulcerative Proctitis, why not treat it topically, with the enema method? And if someone has problems beyond what can be treated via enema, then the pill form is the way to go.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Meta's Bold Plan: Reviving Stablecoins by End of 2026

Updated Category News Views 201

Of Faded Dreams and New Roads Years back, I watched as Meta tripped over itself trying to launch the Libra project. What a train wreck! That was supposed to be the golden ticket for digital payments. Now, it’s back at it like a dog chasing its tail, with plans to revive stablecoins by the end of 2026 through a partnership with third-party vendors. Feels like we’re...

Continue Reading
Healthcare Bluebook Introduces Innovative GLP-1 Savings Program

Updated Category News Views 212

Introducing the GLP-1 Savings Strategy Program Healthcare Bluebook has launched its GLP-1 Savings Strategy Program, a practical next step in its Bluebook Rx services. The program is designed to curb pharmacy spending on GLP-1 medications while giving people clearer choices and a simpler path to care. By putting more control in your hands, it aims to make these essential...

Continue Reading
Daniel Sadan Launches 'House of War' Podcast and Events

Updated Category News Views 126

Introducing the 'House of War' Podcast and Event Series Examining the threat posed by radical Islamism. Daniel Sadan, an influential American businessman and Executive Producer, is thrilled to unveil House of War. This innovative live event and podcast series delves into the global ramifications of the Muslim Brotherhood’s ideology. The concept of "Dar al-Harb" (House...

Continue Reading
Shanghai Electric Drives Clean Energy with New PV Project

Updated Category News Views 258

Shanghai Electric Expands Renewable Energy Efforts Shanghai Electric has made a significant impact in Romania's clean energy sector by signing its latest photovoltaic project in Parau. This landmark initiative showcases the company's commitment to sustainability and innovation within the renewable energy landscape. Milestone Project Signed with Econergy Recently, the...

Continue Reading
ESGold Corp. Charts Path to Profitable Gold Production

Updated Category News Views 133

ESGold Corp. and Its Vision for Growth ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is poised to transform its gold production potential into a reality. The company is a standout player in the mining sector, having developed a high-margin operating model that is attractive to investors. With its strategic initiatives in place, ESGold showcases a clear pathway toward...

Continue Reading